BeStock  
Stocks › Biotechnology › BRVE

Braveheart Bio BRVE

US equityMarket cap rank #2736Biotechnology
$20.39 +$1.12 (+5.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $20.39 0.00%
Open$19.29
Prev close$19.27
Day range$18.83 – $21.16
Volume866.7K
Market cap$1.83B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$45.50+123.1% vs. price
  • Buy 100%
Low $40.00Now $20.39Avg $45.50High $49.00

Recent rating changes

The last 13 actions on file set price targets from $40.00 to $49.00, averaging $44.83.

DateFirmRatingTarget
11 Nov 2026 Goldman Sachs BUY $49.00
9 Nov 2026 Stifel BUY $45.00
7 Nov 2026 Cantor Fitzgerald BUY $40.00
19 Oct 2026 Cantor Fitzgerald BUY $40.00
1 Oct 2026 Stifel BUY $45.00
9 Sep 2026 Stifel BUY $45.00
8 Sep 2026 Goldman Sachs BUY $48.00
6 Sep 2026 Stifel BUY $45.00
31 Aug 2026 TD Cowen BUY –
31 Aug 2026 Cantor Fitzgerald BUY $40.00
31 Aug 2026 Jefferies BUY $48.00
31 Aug 2026 Stifel BUY $45.00
31 Aug 2026 Goldman Sachs BUY $48.00

Discussion

No comments yet — be the first to weigh in on BRVE.

Sign in to join the discussion.

Scroll to Top